Synced daily from ClinicalTrials.gov via AACT. Last sync: .
10 Lifileucel clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 7 indications (including Metastatic Melanoma & Unresectable Melanoma) and 1,688 total planned enrollment. 2 Phase 3 Lifileucel trials and 5 Phase 2 are listed. 4 Lifileucel clinical trials are actively recruiting at 67 U.S. sites across 27 states. Most recent activity: NCT07288203 (Dec 2033).
Where to Participate: All Lifileucel Trial Sites in the U.S. (67 sites across 27 states)
Every actively recruiting Lifileuceltrial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
State
Facility
City
Trial
Map
AL
University of Alabama at Birmingham: The Kirklin Clinic
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma
10 Lifileucel clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 4 are actively recruiting participants. 2 are marked completed.
Are Lifileucel clinical trials recruiting in 2026?
Yes — 4 Lifileucel trials are actively recruiting in 2026, with 67 U.S. sites across 27 states. See the recruiting trials and the per-state site list further down this page.
What conditions is Lifileucel being studied for?
Lifileucel is being studied for Metastatic Melanoma, Unresectable Melanoma, Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Melanoma, Cutaneous Malignant and 11 more. The trials are grouped by indication on this page.
What phase is Lifileucel in?
Lifileucel clinical trials span 2 Phase 3, 5 Phase 2, 3 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors Lifileucel clinical trials?
The lead sponsor across the most Lifileucel trials is Iovance Biotherapeutics, Inc., with 4 additional lead sponsors listed in the data. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming Lifileucelas an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.